Literature DB >> 24250878

Hemorrhagic brain metastases as a manifestation of metastatic malignant melanoma.

Vahid Reza Ostovan1.   

Abstract

Entities:  

Keywords:  Brain Metastases; Hemorrhagic; Malignant Melanoma

Year:  2012        PMID: 24250878      PMCID: PMC3829250     

Source DB:  PubMed          Journal:  Iran J Neurol        ISSN: 2008-384X


× No keyword cloud information.

Introduction

A 53- year-old woman was admitted with chief complaints of progressive dyspnea, numbness, and paresthesia of the right side which had lasted for one month. Four years earlier, her right big toe had amputated due a diagnosis of acral lentiginous melanoma. She had had no problems for three years but then developed cervical lymphadenopathy. Excisional biopsy revealed metastatic melanoma. She also had a thyroid nodule which was proved to be papillary thyroid carcinoma based on fine needle aspiration (FNA) results. Because of metastatic malignant melanoma, she received chemotherapy and radiotherapy. Chest X-ray showed multiple round nodules (Figure 1) and brain computed tomography (CT) scan was in favor of multiple round hyperdense lesions with surrounding edema (Figures 2A, 2B, and 2C).
Figure 1

Chest X-ray shows multiple round nodules in both lungs

Figure 2A, 2B, 2C

Axial brain computed tomography (CT) scan shows multiple hyperdense round lesions with surrounding edema (arrows)

Chest X-ray shows multiple round nodules in both lungs Axial brain computed tomography (CT) scan shows multiple hyperdense round lesions with surrounding edema (arrows) The incidence of malignant melanoma has increased in recent years, i.e. about one in every 70 people will develop melanoma during their lifetime.[1] Central nervous system is the most common site of metastases to the head that occurs in 10-40% of patients with melanoma.[2] Brain metastases are the gravest complications of melanoma and lead to neurologic death in the majority of the patients. Patients who have extracranial metastases, neurologic symptoms, four or more brain metastases, and hydrocephalus and leptomeningeal metastases are at risk for decreased survival.[2, 3] Brain metastases have wide variety of appearances in metastatic melanoma. A usual appearance of melanoma is melanotic pattern in which blood products and melanin cause hyperdensity on brain CT scan, hypersignal intensity on T1-weighted magnetic resonance images (MRI), and low signal intensity on T2-weighted MRI. Other features include small size, amelanism, rapid growth, and being subependymal.[4] Papillary thyroid carcinoma is the most common type of thyroid malignancy with good prognosis. Although brain metastases are very rare (0.1-5.0%) in this type of disease, they may present as hemorrhagic metastases.[5] Unfortunately, during hospitalization, our patient's conditions aggravated and she was intubated as her level of consciousness decreased. As a result, further investigations such as brain MRI were not performed. According to the patient's history which was compatible with metastatic melanoma and her brain CT scan, it seems that she had melanotic brain metastases.
  4 in total

Review 1.  A variety of appearances of malignant melanoma in the head: a review.

Authors:  E J Escott
Journal:  Radiographics       Date:  2001 May-Jun       Impact factor: 5.333

Review 2.  Diagnosis and management of malignant melanoma.

Authors:  B G Goldstein; A O Goldstein
Journal:  Am Fam Physician       Date:  2001-04-01       Impact factor: 3.292

3.  Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features.

Authors:  Jeffrey J Raizer; Wen-Jen Hwu; Katherine S Panageas; Andrew Wilton; Drew E Baldwin; Elizabeth Bailey; Caroline von Althann; Lynne A Lamb; Gladys Alvarado; Mark H Bilsky; Philip H Gutin
Journal:  Neuro Oncol       Date:  2008-02-20       Impact factor: 12.300

4.  Brain metastasis from papillary carcinoma of thyroid gland.

Authors:  Batuk Diyora; Naren Nayak; Hanmant Kamble; Alok Sharma
Journal:  J Neurosci Rural Pract       Date:  2010-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.